• Our Services
    • Care Navigation
    • Personalized Action Plans
    • The Cancer Commons Difference
    • Registering with Cancer Commons
  • Education
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • About Us
    • Our Story
    • Facing Advanced Cancer
    • Meet the Team that Cares
    • Our Core Values
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Testimonials
    • All Testimonials
  • Support Us
    • Donate Now
    • Many Ways to Give
    • What Your Support Makes Possible
  • Our Services
    • Care Navigation
    • Personalized Action Plans
    • The Cancer Commons Difference
    • Registering with Cancer Commons
  • Education
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • About Us
    • Our Story
    • Facing Advanced Cancer
    • Meet the Team that Cares
    • Our Core Values
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Testimonials
    • All Testimonials
  • Support Us
    • Donate Now
    • Many Ways to Give
    • What Your Support Makes Possible
 

Treatment Options

Learn about the latest treatments for advanced cancer. We’ve got it covered, from new FDA approvals to emerging approaches in immunotherapy, targeted therapy, cancer vaccines, modified viruses, and more.

  • February 8, 2022  

    Facing Esophageal Cancer in 2022

    Kaumudi Bhawe, PhD

    Difficulty swallowing, a hoarse voice, or heartburn has led to the dreaded diagnosis of esophageal cancer. What now? Origin, Types, and Stages of Esophageal Cancer If you or a loved one face esophageal cancer, it can be helpful to start by learning more about the disease and your particular diagnosis. Then, you will be prepared to learn about esophageal cancer treatments. Esophageal cancer originates… Read more »

  • February 3, 2022  

    Kidney Cancer Clinical Trials at UCSD Bookmark

    George Lundberg, MD

    Enrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Diego, keeps a running list of clinical trials offered there that are currently enrolling people with kidney cancer.

    .

  • February 3, 2022  

    Kidney Cancer Clinical Trials at UCSF Bookmark

    George Lundberg, MD

    Enrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Francisco, keeps a running list of clinical trials offered there that are currently enrolling people with kidney cancer.

    .

  • February 3, 2022  

    Bladder Cancer Clinical Trials at UCSD Bookmark

    George Lundberg, MD

    Enrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Diego, keeps a running list of clinical trials offered there that are currently enrolling people with bladder cancer.

    .

  • February 3, 2022  

    Transitional Cell Carcinoma Clinical Trials at UCSF Bookmark

    George Lundberg, MD

    Enrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Francisco, keeps a running list of clinical trials offered there that are currently enrolling people with transitional cell carcinoma, the most common form of bladder cancer.

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Peripheral T-Cell Lymphoma Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for peripheral T-cell lymphoma (PTCL).

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Acute Myeloid Leukemia Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for acute myeloid leukemia.

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Small Cell Lung Cancer Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for small cell lung cancer.

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Cervical Cancer Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for cervical cancer.

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Kidney Cancer Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for kidney cancer.

    .

    • «
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • 26
    • »

To me, Cancer Commons has not only been a great resource but I feel the people I’ve dealt with are my friends. They give me a great sense of comfort. My questions and concerns are always addressed very promptly. I would highly recommend Cancer Commons.

Susan
Wife of glioblastoma patient



In a field as complex and dynamic as molecular oncology in 2020, Cancer Commons offers an amazing opportunity for patients with advanced cancer to obtain scientifically up-to-date additional options that may improve both the length and quality of their lives, all free of charge.

Gavin Gordon, PhD
Molecular Pathologist

Cancer Commons, a patient-centric nonprofit, features compassionate experts who build relationships with advanced cancer patients and caregivers to create personalized action plans. Our nurse navigators, PhD scientists, and national experts consult the latest, most-promising research to identify, explain, and help patients access their best-possible diagnostic and treatment options—so everyone feels confident they’ve left no stone unturned.

Don’t miss Cancer Commons Connects
Exclusive monthly insights and stories—from and for our community

Working.

Dealing with Cancer? Let Us Help

Our Services

  • Care Navigation
  • Personalized Action Plans
  • Registering with Cancer Commons
  • Enhanced Services
  • Personal Tumor Boards
  • Frequently Asked Questions (FAQ)

Perspectives

  • Latest Research
  • Treatment Options
  • Molecular Testing
  • Navigating Treatment
  • Living with Cancer
  • Patient Stories
  • Curious Dr. George
  • The Big Picture
  • Peer-Reviewed Publications

Organization

  • Our Story
  • Our Team
  • Our Core Values
  • Contact Us
  • Board of Directors
  • Partners
  • Expert Physician Advisors

About Us

  • News and Events
  • Contact Us
  • Financial Documents

Support & Giving

  • Contribute Now
  • Many Ways to Give
  • What Your Support Makes Possible
  • Testimonials


Donate

Cancer Commons
650 Castro Street, Suite 120-522
Mountain View, CA 94041, USA
650-289-4044

Patients Hotline

877-971-1200

  • Privacy Policy

© 2023 Cancer Commons.